CH679045A5 - - Google Patents
Download PDFInfo
- Publication number
- CH679045A5 CH679045A5 CH2423/88A CH242388A CH679045A5 CH 679045 A5 CH679045 A5 CH 679045A5 CH 2423/88 A CH2423/88 A CH 2423/88A CH 242388 A CH242388 A CH 242388A CH 679045 A5 CH679045 A5 CH 679045A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- hydrogen
- carbon atoms
- radical
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3721406 | 1987-06-29 | ||
DE3721407 | 1987-06-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH679045A5 true CH679045A5 (hu) | 1991-12-13 |
Family
ID=25857047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH2423/88A CH679045A5 (hu) | 1987-06-29 | 1988-06-24 |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS6426599A (hu) |
KR (1) | KR890000520A (hu) |
AU (1) | AU1840988A (hu) |
BE (1) | BE1002663A4 (hu) |
CH (1) | CH679045A5 (hu) |
DK (1) | DK353788A (hu) |
ES (1) | ES2010283A6 (hu) |
FR (1) | FR2617171B1 (hu) |
GB (1) | GB2206352B (hu) |
IL (1) | IL86876A0 (hu) |
IT (1) | IT1221065B (hu) |
LU (1) | LU87262A1 (hu) |
NL (1) | NL8801640A (hu) |
NZ (1) | NZ225188A (hu) |
SE (1) | SE8802413L (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU206890B (en) * | 1986-10-13 | 1993-01-28 | Sandoz Ag | Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components |
GB8826452D0 (en) * | 1988-11-11 | 1988-12-14 | Sandoz Ltd | Peptide derivatives |
GB8813339D0 (en) * | 1988-06-06 | 1988-07-13 | Sandoz Ltd | Improvements in/relating to organic compounds |
MY106120A (en) * | 1988-12-05 | 1995-03-31 | Novartis Ag | Peptide derivatives. |
US5776894A (en) * | 1988-12-05 | 1998-07-07 | Novartis Ag | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors |
US5753627A (en) * | 1988-12-05 | 1998-05-19 | Novartis Ag | Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis |
JP2882679B2 (ja) * | 1989-04-26 | 1999-04-12 | ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド | 線状ソマトスタチン類似体 |
US5633263A (en) * | 1989-04-26 | 1997-05-27 | The Administrators Of The Tulane Educational Fund | Linear somatostatin analogs |
GB9004017D0 (en) * | 1990-02-22 | 1990-04-18 | Krenning Eric P | Improvements in or relating to organic compounds |
US5632969A (en) * | 1994-10-13 | 1997-05-27 | Merck & Co., Inc. | N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications |
US5556939A (en) * | 1994-10-13 | 1996-09-17 | Merck Frosst Canada, Inc. | TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
AUPN999096A0 (en) * | 1996-05-22 | 1996-06-13 | Northstar Biologicals Pty Ltd | Peptides, antibodies, vaccines & uses thereof |
EP1198478B1 (en) * | 2000-07-31 | 2005-03-23 | Dabur Research Foundation | Somatostatin analogs and their use for the treatment of cancer |
HUP0401535A3 (en) | 2001-03-08 | 2009-07-28 | Univ Tulane | Somatostatin antagonists and their use |
EP1397150A4 (en) * | 2001-04-09 | 2005-01-26 | Administrators Ofthe Tulane Ed | AGONISTS OF SOMATOSTATIN |
KR100432178B1 (ko) * | 2002-01-29 | 2004-05-22 | 홍수천 | 철제배관의 부식방지능을 갖는 수정화 장치 |
KR100462968B1 (ko) * | 2002-06-10 | 2004-12-23 | 주식회사 리독스 | 배관내의 물의 살균, 악취제거 및 스케일 발생 방지를위한 수처리 장치 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU85269A1 (fr) * | 1984-03-26 | 1985-10-14 | Techland S A | Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux |
HUT42101A (en) * | 1985-01-07 | 1987-06-29 | Sandoz Ag | Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds |
-
1988
- 1988-06-24 CH CH2423/88A patent/CH679045A5/de not_active IP Right Cessation
- 1988-06-27 FR FR888808720A patent/FR2617171B1/fr not_active Expired - Fee Related
- 1988-06-27 IL IL86876A patent/IL86876A0/xx unknown
- 1988-06-27 GB GB8815257A patent/GB2206352B/en not_active Expired - Lifetime
- 1988-06-27 AU AU18409/88A patent/AU1840988A/en not_active Abandoned
- 1988-06-27 DK DK353788A patent/DK353788A/da not_active Application Discontinuation
- 1988-06-27 BE BE8800732A patent/BE1002663A4/fr not_active IP Right Cessation
- 1988-06-27 NZ NZ225188A patent/NZ225188A/en unknown
- 1988-06-28 NL NL8801640A patent/NL8801640A/nl not_active Application Discontinuation
- 1988-06-28 JP JP63162370A patent/JPS6426599A/ja active Pending
- 1988-06-28 IT IT48133/88A patent/IT1221065B/it active
- 1988-06-28 KR KR1019880007817A patent/KR890000520A/ko not_active Application Discontinuation
- 1988-06-28 LU LU87262A patent/LU87262A1/fr unknown
- 1988-06-28 SE SE8802413A patent/SE8802413L/ not_active Application Discontinuation
- 1988-06-29 ES ES8802038A patent/ES2010283A6/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NZ225188A (en) | 1991-04-26 |
SE8802413L (sv) | 1988-12-30 |
BE1002663A4 (fr) | 1991-04-30 |
KR890000520A (ko) | 1989-03-15 |
DK353788D0 (da) | 1988-06-27 |
IT8848133A0 (it) | 1988-06-28 |
FR2617171A1 (fr) | 1988-12-30 |
GB2206352B (en) | 1990-10-31 |
IT1221065B (it) | 1990-06-21 |
GB8815257D0 (en) | 1988-08-03 |
FR2617171B1 (fr) | 1994-10-14 |
IL86876A0 (en) | 1988-11-30 |
DK353788A (da) | 1988-12-30 |
AU1840988A (en) | 1989-01-05 |
JPS6426599A (en) | 1989-01-27 |
LU87262A1 (fr) | 1989-03-08 |
GB2206352A (en) | 1989-01-05 |
SE8802413D0 (sv) | 1988-06-28 |
ES2010283A6 (es) | 1989-11-01 |
NL8801640A (nl) | 1989-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH682632A5 (de) | Mit Zuckerresten modifizierte Peptide. | |
EP1161452B1 (de) | Kovalent verbrückte insulindimere | |
CH679045A5 (hu) | ||
CH682152A5 (hu) | ||
DE2321174A1 (de) | Nonapeptidamidderivate und verfahren zu ihrer herstellung | |
DE3207311A1 (de) | Neue n-acylpolypeptide und ihre herstellung | |
DE3333640A1 (de) | Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung | |
DE2705514C3 (de) | Nonapeptide und diese enthaltende Arzneimittel | |
CH626328A5 (en) | Process for the preparation of somatostatin analogues | |
CH615904A5 (en) | Process for the preparation of L-leucine-13-motilin | |
CH649562A5 (de) | Derivate des methionin-enzephalins. | |
EP0589927A1 (de) | Geschützter aminosäurebaustein, herstellung und verwendung | |
DE2112553C3 (de) | 1 -alpha-Aminolsobuttersäurecorticotropinpeptide, deren Derivate, Säureadditionssalze und Komplexe sowie Arzneipräparate | |
US4405607A (en) | Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use | |
DE3328952A1 (de) | Neue polypeptide, verfahren zu ihrer herstellung, pharmazeutische praeparate welche sie enthalten, sowie ihre verwendung | |
DE2739440A1 (de) | Pentapeptide und sie enthaltende arzneimittel | |
DE2804566A1 (de) | Polypeptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
DE2628006C2 (de) | Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung | |
EP0095557B1 (de) | Polypeptide mit antagonistischen Eigenschaften gegenüber der Substanz P, Verfahren zu ihrer Herstellung, deren Verwendung und Verfahren zum Reinigen von Polypeptiden | |
DE2602803A1 (de) | Octapeptidderivate und verfahren zu deren herstellung | |
DE3820770A1 (de) | Polypeptide | |
DE2534085A1 (de) | Adrenocorticotrope polypeptide, deren salze und komplexe sowie arzneimittel | |
DE2534086A1 (de) | Polypeptide mit acth-aehnlicher wirkung, ihre salze und komplexe, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel | |
DE3790635B4 (de) | Verfahren zur Herstellung eines Peptidalkohols und Ausgangsverbindungen dafür | |
EP0491361A2 (de) | Kurze Peptide mit Insulinwirkung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |